Skip to main content
. 2022 Jun 27;10(4):e01447-22. doi: 10.1128/spectrum.01447-22

TABLE 1.

Characteristics of healthy participants and IDUs in this study

Sociodemographics Healthy controla Intravenous drug users (IDUs)
Neg-IDUsd HIV-1+ HCV+ HIV-1/hCV+ HBV+
No. of individuals 11 23 26 11 29 10
Age 31 (19 to 60) 30 (21 to 37) 31 (22 to 53) 29 (21 to 39) 31 (18 to 43) 30.5 (28 to 36)
Gender (male/female) 11/0 23/0 20/0 10/1 25/4 11/0
Higher education 9.1% 0 0 0 0 0
Married 10 8 7 4 6 2
Single/divorced 1 15 20 7 23 8
Duration of drug use/y 3.5 (1 to 16) 8.0 (1 to 20) 4.0 (1 to 13) 10.0 (1 to 22) 6.0 (2 to 15)
Frequency of drug use (times/day) 3.0 (0.3 to 7) 3.0 (1.5 to 10) 3.0 (1 to 3) 3.5 (1 to 9) 4.0 (1 to 5)
Syringe sharing 38.1% 60.0% 30.0% 50.0% 77.8%
Times of repeated syringe use 1.0 (1 to 10) 2.0 (1 to 8) 1.5 (1 to 5) 2.0 (1 to 10) 3.0 (1 to 5)
Cleaning method
 Tap water 75% 50% 66.7% 78.6% 71.4%
 Boiled water 25% 28.6% 16.7% 7.1% 14.3%
 Never 0 21.4% 16.7% 14.3% 14.3%
STDb history 10.0% 5.9% 33.3% 0 22.2%
Sexual partners 3.0 (0 to 10) 1.0 (0 to 6) 2.0 (0 to 5) 1.0 (0 to 5) 3.0 (1 to 10)
Ways of drug use
 Intravenous 33.3% 23.8% 70.0% 65.0% 44.4%
 Intravenous and oral 66.7% 76.2% 30.0% 35.0% 55.6%
Drug rehabilitation times 2.0 (1 to 4) 2.0 (1 to 15) 2.0 (1 to 5) 4.0 (2 to 15) 2.5 (1 to 5)
Other drug usec 74.7% 75.0% 85.7% 78.9% 100%
a

Healthy control group (non-IDU and without main viral infections).

b

STD, sexually transmitted disease.

c

IDUs without HIV-1/HCV/HBV infections.

d

Other drugs include Diazepam and Triazolam.